After two decades of growth driven largely by scale and generics, 2025 proved to be a reset year for India’s pharmaceutical, healthcare and medical devices sectors. Policy reform, a renewed focus on ...
The MarketWatch News Department was not involved in the creation of this content. -- Zoomex Outlines Liquidity and Execution Strategy as Automated Trading Activity Increases -- Zoomex Details ...
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results